Fogarty International Center
-
Novel way to neutralize Rift Valley Fever Virus
The discovery of monoclonal antibodies that neutralize Rift Valley Fever Virus — an emerging infection with pandemic potential — lays the foundation for future therapeutic antibody development. Read MoreApr 1, 2021
-
Chancellor Zeppos responds to decision to rescind DACA, university offers resources and support
Chancellor Nicholas S. Zeppos and other university leaders opposed the decision to rescind the DACA program today and reiterated the university’s commitment to supporting its students regardless of their immigration status, citizenship or nationality. Read MoreSep 5, 2017
-
Preserving NIH’s Fogarty International Center crucial for global health efforts
This week Douglas Heimburger, M.D., M.S., professor of Medicine at Vanderbilt, joined a growing chorus calling for preservation of the Fogarty International Center of the National Institutes of Health (NIH). Read MoreMay 26, 2017
-
Grants bolster HIV-focused research capacity
The Vanderbilt Institute for Global Health (VIGH) has received two new grants from the Fogarty International Center of the National Institutes of Health (NIH) to build HIV-focused research capacity with key partners in Zambia, Mozambique and Brazil. Read MoreAug 20, 2015
-
VUSM student receives AMA Foundation Minority Scholars Award
The American Medical Association (AMA) Foundation and the AMA Minority Affairs Section recently named Dagoberto Ordonez, a second-year medical student at Vanderbilt University School of Medicine, a 2015 AMA Foundation Minority Scholars Award recipient. Read MoreJun 25, 2015
-
‘Acid test’ for cervical cancer
An inexpensive, low-tech test for cervical cancer may be a good option for screening for the disease among HIV-infected women in developing countries. Read MoreFeb 21, 2012